| Behavioral, metabolic, and lipidomic characterization of the 5xFADxTg30 mouse model of Alzheimer’s disease JPS Marshall, K Huynh, GI Lancaster, J Ng, JM Collins, G Pernes, A Liang, ... Iscience 27 (2), 2024 | | 2024 |
| Expression of Concern: Characterising the spatial and temporal brain metal profile in a mouse model of tauopathy. SS Rao, L Lago, RG de Vega, L Bray, DJ Hare, D Clases, PA Doble, ... Metallomics, 2023 | | 2023 |
| Retraction Note: Deferiprone Treatment in Aged Transgenic Tau Mice Improves Y-Maze Performance and Alters Tau Pathology SS Rao, L Lago, I Volitakis, JJ Shukla, G McColl, DI Finkelstein, PA Adlard Neurotherapeutics 20 (6), 1894, 2023 | | 2023 |
| Alterations in iron content, iron-regulatory proteins and behaviour without tau pathology at one year following repetitive mild traumatic brain injury SMA Juan, M Daglas, PH Truong, C Mawal, PA Adlard Acta Neuropathologica Communications 11 (1), 118, 2023 | 1 | 2023 |
| Intracerebroventricular delivery of glatiramer acetate: proof-of-concept for the treatment of Alzheimer’s disease by promoting innate phagocytosis and antagonizing amyloid-β … X Huang, F Chen, L Doughty, QX Li, W Ou, Y Li, C Drysdale, A Alrehaili, ... | | 2023 |
| Tailored behavioural tests reveal early and progressive cognitive deficits in M1000 prion disease M Senesi, V Lewis, PA Adlard, DI Finkelstein, JH Kim, SJ Collins Neurobiology of Disease 180, 106075, 2023 | | 2023 |
| Distribution of Copper, Iron, and Zinc in the Retina, Hippocampus, and Cortex of the Transgenic APP/PS1 Mouse Model of Alzheimer’s Disease SM Hosseinpour Mashkani, DP Bishop, N Raoufi-Rad, PA Adlard, ... Cells 12 (8), 1144, 2023 | 3 | 2023 |
| Prophylaxis and treatment of cognitive dysfunction and decline P Adlard, S Portbury US Patent 11,602,538, 2023 | | 2023 |
| Purchase Agreement F Edward, J Beverly | | 2023 |
| Zinc and traumatic brain injury SMA Juan, M Daglas, PH Truong, PA Adlard Vitamins and Minerals in Neurological Disorders, 171-192, 2023 | | 2023 |
| Deferiprone attenuates neuropathology and improves outcome following traumatic brain injury M Daglas, PH Truong, LQ Miles, SMA Juan, SS Rao, PA Adlard British journal of pharmacology 180 (2), 214-234, 2023 | 6 | 2023 |
| Altered amyloid precursor protein, tau‐regulatory proteins, neuronal numbers and behaviour, but no tau pathology, synaptic and inflammatory changes or memory deficits, at 1 … SMA Juan, M Daglas, PA Adlard European Journal of Neuroscience 56 (9), 5342-5367, 2022 | 7 | 2022 |
| ATH434 rescues pre-motor hyposmia in a mouse model of parkinsonism LC Beauchamp, XM Liu, LJ Vella, PA Adlard, AI Bush, DI Finkelstein, ... Neurotherapeutics 19 (6), 1966-1975, 2022 | 3 | 2022 |
| Tau pathology, metal dyshomeostasis and repetitive mild traumatic brain injury: an unexplored link paving the way for neurodegeneration SMA Juan, M Daglas, PA Adlard Journal of Neurotrauma 39 (13-14), 902-922, 2022 | 12 | 2022 |
| Characterization of the spatial distribution of metals and profile of metalloprotein complexes in a mouse model of repetitive mild traumatic brain injury SMA Juan, M Daglas, AP Gunn, L Lago, PA Adlard Metallomics 14 (12), mfac092, 2022 | 5 | 2022 |
| The compound ATH434 prevents alpha-synuclein toxicity in a murine model of multiple system atrophy DI Finkelstein, JJ Shukla, RA Cherny, JL Billings, E Saleh, N Stefanova, ... Journal of Parkinson's Disease 12 (1), 105-115, 2022 | 11 | 2022 |
| Deferiprone Treatment in Aged Transgenic Tau Mice Improves Y-Maze Performance and Alters Tau Pathology (vol 18, pg 1081, 2021) SS Rao, L Lago, I Volitakis, JJ Shukla, G McColl, DI Finkelstein, PA Adlard NEUROTHERAPEUTICS 18 (4), 2759-2761, 2021 | | 2021 |
| The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson's disease (vol 5, 53, 2017) DI Finkelstein, JL Billings, PA Adlard, S Ayton, A Sedjahtera, CL Masters, ... ACTA NEUROPATHOLOGICA COMMUNICATIONS 9 (1), 2021 | | 2021 |
| Exercise ameliorates aberrant synaptic plasticity without enhancing adult-born cell survival in the hippocampus of serotonin transporter knockout mice C Wilson, J Rogers, F Chen, S Li, PA Adlard, AJ Hannan, T Renoir Brain Structure and Function 226, 1991-1999, 2021 | 7 | 2021 |
| Deferiprone treatment in aged transgenic tau mice improves Y-maze performance and alters tau pathology SS Rao, L Lago, I Volitakis, JJ Shukla, G McColl, DI Finkelstein, PA Adlard Neurotherapeutics 18 (2), 1081-1094, 2021 | 20 | 2021 |
